Literature DB >> 11004687

Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.

D Tong, E Kucera, E Schuster, R K Schmutzler, H Swoboda, A Reinthaller, S Leodolter, R Zeillinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11004687     DOI： 10.1002/1097-0215(20001015)88:2<319::aid-ijc27>3.0.co;2-x

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  4 in total

1.  Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers.

Authors:  Kada Peela Bheeman Dinesh; Halagowder Devaraj; Vadivel Murugan; Ramamurthy Rajaraman; Sivasidhambaram Niranjali
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

2.  Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

Authors:  Andrew D Spearman; Kevin Sweet; Xiao-Ping Zhou; Jane McLennan; Fergus J Couch; Amanda Ewart Toland
Journal:  J Clin Oncol       Date:  2008-09-29       Impact factor: 44.544

3.  A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1.

Authors:  Karen M Chisholm; Sarah D Aubert; Krister P Freese; Virginia A Zakian; Mary-Claire King; Piri L Welcsh
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

Review 4.  BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.

Authors:  Melissa Burgess; Shannon Puhalla
Journal:  Front Oncol       Date:  2014-02-27       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.